Terms: = Lung cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL
286 results:
1. [Intraductal carcinomas of the salivary glands: a clinicopathological and molecular genetic analysis of twenty-seven cases].
Sun Q; Sun JJ; Wang M; Zhang L; Zhang XW; Wei JG; Kong LF; Li J
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):250-256. PubMed ID: 38433052
[No Abstract] [Full Text] [Related]
2. The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants.
Materna M; Delmonte OM; Bosticardo M; Momenilandi M; Conrey PE; Charmeteau-De Muylder B; Bravetti C; Bellworthy R; Cederholm A; Staels F; Ganoza CA; Darko S; Sayed S; Le Floc'h C; Ogishi M; Rinchai D; Guenoun A; Bolze A; Khan T; Gervais A; Krüger R; Völler M; Palterer B; Sadeghi-Shabestari M; Langlois de Septenville A; Schramm CA; Shah S; Tello-Cajiao JJ; Pala F; Amini K; Campos JS; Lima NS; Eriksson D; Lévy R; Seeleuthner Y; Jyonouchi S; Ata M; Al Ali F; Stittrich A; Deswarte C; Pereira A; Mégret J; Le Voyer T; Bastard P; Berteloot L; Dussiot M; Vladikine N; Cardenas PP; Jouanguy E; Alqahtani M; Hasan A; Thanaraj TA; Rosain J; Al Qureshah F; Sabato V; Alyanakian MA; Leruez-Ville M; Rozenberg F; Haddad E; Regueiro JR; Toribio ML; Kelsen JR; Salehi M; Nasiri S; Torabizadeh M; Rokni-Zadeh H; Changi-Ashtiani M; Vatandoost N; Moravej H; Akrami SM; Mazloomrezaei M; Cobat A; Meyts I; Toyofuku E; Nishimura M; Moriya K; Mizukami T; Imai K; Abel L; Malissen B; Al-Mulla F; Alkuraya FS; Parvaneh N; von Bernuth H; Beetz C; Davi F; Douek DC; Cheynier R; Langlais D; Landegren N; Marr N; Morio T; Shahrooei M; Schrijvers R; Henrickson SE; Luche H; Notarangelo LD; Casanova JL; Béziat V
Science; 2024 Mar; 383(6686):eadh4059. PubMed ID: 38422122
[TBL] [Abstract] [Full Text] [Related]
3. Strophanthidin Induces Apoptosis of Human lung Adenocarcinoma Cells by Promoting TRAIL-DR5 Signaling.
Tian X; Gu L; Zeng F; Liu X; Zhou Y; Dou Y; Han J; Zhao Y; Zhang Y; Luo Q; Wang F
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398629
[TBL] [Abstract] [Full Text] [Related]
4. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
5. [A Case of Triple Negative Breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
[TBL] [Abstract] [Full Text] [Related]
6. Nomogram for predicting the overall survival and cancer-specific survival of patients with intraductal carcinoma of the prostate.
Cui Y; Lin J; Sun D; Zhang H; Diao T; Fu Q
J Cancer Res Clin Oncol; 2024 Jan; 150(2):45. PubMed ID: 38281261
[TBL] [Abstract] [Full Text] [Related]
7. The over diagnosis of diffuse mesothelioma: An analysis of 311 cases with recommendations for the avoidance of pitfalls.
Carney JM; Roggli VL; Glass CH; Piña-Oviedo S; Pavlisko EN
Ann Diagn Pathol; 2024 Feb; 68():152248. PubMed ID: 38182448
[TBL] [Abstract] [Full Text] [Related]
8. Enrichment of lung cancer computed tomography collections with AI-derived annotations.
Krishnaswamy D; Bontempi D; Thiriveedhi VK; Punzo D; Clunie D; Bridge CP; Aerts HJWL; Kikinis R; Fedorov A
Sci Data; 2024 Jan; 11(1):25. PubMed ID: 38177130
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of MTFR1 promotes cancer progression and drug-resistance on cisplatin and is related to the immune microenvironment in lung adenocarcinoma.
Li QY; Guo Q; Luo WM; Luo XY; Ji YM; Xu LQ; Guo JL; Shi RS; Li F; Lin CY; Zhang J; Ke D
Aging (Albany NY); 2024 Jan; 16(1):66-88. PubMed ID: 38170222
[TBL] [Abstract] [Full Text] [Related]
10. Hyperfractionated Accelerated Radiotherapy Versus Stereotactic Body Radiotherapy in the Treatment of Limited-Stage Small Cell lung cancer: A Matched-Pair Analysis.
Yang L; Lu X; Luo J; Huang D; Dai X; Yang Y; Dai N; Xiong Y
Am J Clin Oncol; 2024 Mar; 47(3):115-121. PubMed ID: 37981702
[TBL] [Abstract] [Full Text] [Related]
11. Validated extended multiplexed LC-MS/MS assay for the quantification of adagrasib and sotorasib in human plasma, together with four additional SMIs.
Kruithof PD; de Beer YM; Gulikers JL; Stolk LML; Hendriks LEL; Croes S; van Geel RMJM
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Dec; 1231():123918. PubMed ID: 37979367
[TBL] [Abstract] [Full Text] [Related]
12. The NCI Imaging Data Commons as a platform for reproducible research in computational pathology.
Schacherer DP; Herrmann MD; Clunie DA; Höfener H; Clifford W; Longabaugh WJR; Pieper S; Kikinis R; Fedorov A; Homeyer A
Comput Methods Programs Biomed; 2023 Dec; 242():107839. PubMed ID: 37832430
[TBL] [Abstract] [Full Text] [Related]
13. Combined influence of nutritional and inflammatory status and depressive symptoms on mortality among US cancer survivors: Findings from the NHANES.
Yao J; Chen X; Meng F; Cao H; Shu X
Brain Behav Immun; 2024 Jan; 115():109-117. PubMed ID: 37820973
[TBL] [Abstract] [Full Text] [Related]
14. Definitive ablative stereotactic partial breast irradiation in early stage inoperable breast cancer.
Miljanic M; Nwachukwu C; Rahimi A
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15553-15559. PubMed ID: 37648809
[TBL] [Abstract] [Full Text] [Related]
15. Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database.
Wang Y; Liang Y; Ye F; Luo D; Jin Y; Li Y; Zhao W; Chen B; Wang L; Yang Q
Cancer Med; 2023 Sep; 12(18):18597-18610. PubMed ID: 37605516
[TBL] [Abstract] [Full Text] [Related]
16. Quantifying the Effect of 4-Dimensional Computed Tomography-Based Deformable Dose Accumulation on Representing Radiation Damage for Patients with Locally Advanced Non-Small Cell lung cancer Treated with Standard-Fractionated Intensity-Modulated Radiation Therapy.
He Y; Cazoulat G; Wu C; Svensson S; Almodovar-Abreu L; Rigaud B; McCollum E; Peterson C; Wooten Z; Rhee DJ; Balter P; Pollard-Larkin J; Cardenas C; Court L; Liao Z; Mohan R; Brock K
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):231-241. PubMed ID: 37552151
[TBL] [Abstract] [Full Text] [Related]
17. Impact of breath hold on regional nodal irradiation and heart volume in field in left breast cancer adjuvant irradiation.
Abouegylah M; Elemary O; Ahmed AA; ElFeky AM; Fayed H; Gawish M; Mahmoud AA; Gawish A
Clin Transl Oncol; 2024 Jan; 26(1):288-296. PubMed ID: 37382756
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of appropriate conditions for Oncomine DxTT testing of FFPE specimens for driver gene alterations in non-small cell lung cancer.
Iwama E; Yamamoto H; Okubo F; Ijichi K; Ibusuki R; Shiaraishi Y; Yoneshima Y; Tanaka K; Oda Y; Okamoto I
Thorac Cancer; 2023 Aug; 14(23):2288-2296. PubMed ID: 37345344
[TBL] [Abstract] [Full Text] [Related]
19. Identifying potential targets for lung cancer intervention by analyzing the crosstalk of cancer-associated fibroblasts and immune and metabolism microenvironment.
Wei S; Bao M; Zhu Y; Zhang W; Jiang L
Environ Toxicol; 2023 Aug; 38(8):1951-1967. PubMed ID: 37186041
[TBL] [Abstract] [Full Text] [Related]
20. Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in lung Adenocarcinoma.
Fan Z; Wu S; Sang H; Li Q; Cheng S; Zhu H
Mediators Inflamm; 2023; 2023():9162249. PubMed ID: 37035759
[TBL] [Abstract] [Full Text] [Related]
[Next]
